The date is drawing near for the 9th Annual Best Practice Series, Endocrine Summit, to be held in Mumbai. Distinguished international experts will join us at this program to share the latest clinical insights related to endocrinology. These experts will provide a unique and enriching educational experience and will answer your pressing questions important to your practice.

We look forward to your participation in the Endocrine Summit on 28th & 29th April, 2018 in Mumbai.

Scientific Topics:

  • Adult Growth Hormone Deficiency (GHD)

  • Long Term Care in Women with PCOS

  • Subclinical Hyperthyroidism & Hypothyroidism

  • Pathophysiology of Obesity

  • Medical Management in Obesity

  • Primary Hyperparathyroidism

  • Osteoporosis


Program Faculty

  Beverly M. K. Biller  

Beverly M. K. Biller, MD, FACP

  Professor of Medicine, Harvard Medical School, Endocrinologist,
Massachusetts General Hospital, Neuroendocrine Clinical Center, Boston,
Massachusetts, USA
Dr. Beverly Biller is a Professor of Medicine at the Harvard Medical School and a practicing Endocrinologist at the Massachusetts General Hospital,(MGH) Neuroendocrine Clinical Center Boston, Massachusetts, USA. She obtained her MD from University of Oklahoma College of Medicine in 1983 and completed her Residency at the Beth Israel Deaconess Medical Center and Fellowship at the Massachusetts General Hospital. Dr. Biller has been in practice for 35 years. Dr. Biller's major clinical and research interests include the diagnosis and treatment of Cushing's disease, prolactinomas, acromegaly, other pituitary tumors and sellar masses and pituitary hormone deficiencies in adults. She has numerous articles to her credit and has held and holds editorial roles in leading journals.
  Henry Kronenberg  

Henry Kronenberg, MD

  Chief, Endocrine Unit,
Massachusetts General Hospital Professor of Medicine,
Harvard Medical School, Boston, Massachusetts, USA
Dr. Henry Kronenberg is Chief of the Endocrine Unit at the Massachusetts General Hospital and Professor of Medicine at the Harvard Medical School. Dr. Kronenberg's laboratory in recent years has used a number of genetically altered strains of mice to establish the role of signaling by the PTH/PTHrP receptor in bone. Dr. Kronenberg received his BA from Harvard University, his MD from Columbia University, his medical house officer training at the Massachusetts General Hospital, and post-doctoral training at NIH, MIT, and the MGH. Dr. Kronenberg has served as President of the American Society for Bone and Mineral Research and as a member of the Board of Directors of the International Bone and Mineral Society (IBMS); he is currently the Vice President of the IBMS. He has served on the Council of the Endocrine Society and the Endocrine Society's Vice President for Basic Science; he has served as the Endocrine Society's representative on the FASEB Board of Directors. He has served on the General Medicine B NIH Study Section and as a member of the Board of Scientific Counselors of the National Institute of Dental and Craniofacial Research; he is currently on the Council of the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
  Richard S. Legro  

Richard S. Legro, MD

  Professor of Medicine, Obstetrics & Gynecology and Public Health Sciences,
Milton S. Hershey Medical Centre,
Penn State College of Medicine, Hershey, Pennsylvania, USA
Dr. Richard S. Legro is a Professor in the Department of Obstetrics and Gynecology at Penn State University College of Medicine in Hershey, PA. He received his medical degree from the Mount Sinai School of Medicine in New York, NY, completed his residency in Obstetrics and Gynecology at Magee Womens Hospital at the University of Pittsburgh in Pittsburgh, PA and a fellowship in Reproductive Endocrinology and Infertility at the University of Southern California in Los Angeles. His research and clinical practice are primarily focused on polycystic ovary syndrome (PCOS). He established at M.S. Hershey Medical Center one of the first clinics devoted to the treatment of PCOS. He is particularly interested in the familial contributions to the syndrome and the role of obesity, as well as developing treatments which improve fertility, the focus of the OWL-PCOS study. Dr. Legro is also the lead investigator of the multi-center sponsored trials Pregnancy in Polycystic Ovary Syndrome I and II. He has published over 175 articles in medical journals and books in the field of reproductive endocrinology. He serves on the editorial board for the Journal of Clinical Endocrinology and Metabolism, Human Reproduction, and Endocrine Reviews. He has received many awards including the Presidential Achievement Award from the Society for Gynecologic Investigation.
  Anand Vaidya  

Anand Vaidya, MD, MMSc

  Director, Center for Adrenal Disorders, Assistant Professor of Medicine,
Harvard Medical School, Division of Endocrinology,
Diabetes, and Hypertension, Brigham and Women's Hospital, Boston,
Massachusetts, USA
Dr. Anand Vaidya is Director, Center for Adrenal Disorders and Assistant Professor of Medicine, Harvard Medical School Division of Endocrinology, Diabetes, and Hypertension at the Brigham and Women's Hospital. Dr. Vaidya graduated from Harvard Medical School and completed his residency and fellowship training at Brigham and Women's Hospital. Dr. Vaidya's dedication to treating patients with adrenal diseases is directly linked to his research goals aimed at improving the understanding and treatments for these conditions. He has published numerous articles and text book chapters and has editorial responsibilities in several leading journals such as Journal of Clinical Endocrinology and Metabolism (JCEM) , Endocrine Reviews, Circulation, New England Journal of Medicine (NEJM), Diabetologia, Steroids, Endocrine Practice, Clinical Endocrinology, European Journal of Endocrinology (EJE), Hypertension, American Journal of Hypertension (AJH) and The British Medical Journal (BMJ).
  Leonard Wartofsky  

Leonard Wartofsky, MD, MPH, MACP

  Professor of Medicine, Georgetown University School of Medicine, Chairman Emeritus,
Department of Medicine, Faculty in Endocrinology, MedStar Washington Hospital Center,
Washington DC, USA
Dr. Wartofsky is Professor of Medicine, Georgetown University School of Medicine and Chairman Emeritus, Department of Medicine, MedStar Washington Hospital Center. He trained in internal medicine at Barnes Hospital, Washington University and in endocrinology with Dr. Sidney Ingbar, Harvard University Service, Thorndike Memorial Laboratory, Boston. Dr. Wartofsky is past President of both the American Thyroid Association and The Endocrine Society. He is the editor of books on thyroid cancer for both physicians and for patients, and thyroid cancer is his primary clinical focus. He is the author or coauthor of over 350 articles and book chapters in the medical literature, is recent past Editor-in-Chief of the Journal of Clinical Endocrinology & Metabolism, and is the current Editor-in-Chief of Endocrine Reviews.
  Donna H. Ryan  

Donna H. Ryan, MD

  Professor Emeritus, Associate Executive Director, Clinical Research,
Pennington Biomedical Research Center, Baton Rouge,
Louisiana, USA
Dr. Donna Ryan is Professor and Associate Executive Director for Clinical Research at the Pennington Biomedical Research Center. Dr. Ryan’s interest in obesity research was mentored by George Bray, beginning with a 1992 dose-ranging study of sibutramine. She has been an Investigator on DPP (Diabetes Prevention Program), Co PI of POUNDS Lost (macronutrient approaches to weight loss) and Co-PI of Look AHEAD (a study of lifestyle intervention designed to produce ~10% weight loss in diabetic persons). Dr. Ryan is PI of LOSS (Louisiana Obese Subjects Study), a pragmatic clinical trial of intensive medical therapy for severe obesity conducted in six Louisiana primary care clinics as part of their routine practice. Since 1998 she has served as Co PI for the CORE program (Centers of Obesity Research and Education), which brings continuing education in obesity management to health care professionals. She is an editorial board member for Obesity Management and Obesity Reviews. Dr. Ryan's scholarly activities include authorship of 104 original publications and 27 chapters and reviews, primarily in the field of obesity.
To View Scientific Program Agenda Click here

For Registration and More information about Endocrine Summit 2018,
E-mail us at

About Endocrine Society
Founded in 1916, the Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. The mission of the Endocrine Society is to advance excellence in endocrinology and promote its essential and integrative role in scientific discovery, medical practice and human health. The Endocrine Society is an international body with more than 18,000 members in 122 countries. The Society's diverse membership represents medicine, molecular and cellular biology, biochemistry, physiology, genetics, immunology, education, industry and allied health fields. The Society works to foster a greater understanding of endocrinology amongst the general public and practitioners of complementary medical disciplines.

Supported by an unrestricted
educational grant from
In Association with
Sun Pharma   Sun Pharma